A decade of blood biomarkers for Alzheimer’s Disease research: an evolving field, improving study designs, and the challenge of replication

Manuscript Number: 

17-0531R1

Author(s): 
Alison L. Baird, Richard Dobson, Abdul Hye, Simon Lovestone, Liu Shi, Madhav Thambisetty, Sarah Westwood

Disclosures

Alison L. Baird

  • Nothing to Disclose

Richard Dobson

  • Nothing to Disclose
    Grants
    • Agency: 
      Ely Lilly

Abdul Hye

  • Nothing to Disclose

Simon Lovestone

  • Consulting Fees:
    Optum Labs - single meeting expenses only Eisai - speakers fees of <£2000 classified as consultancy MSD - single meeting fees of <£2000 SomaLogic - unpaid consultancy but expenses paid
    Lecture Fees:
    Eisai - speakers fees of <£2000 classified as consultancy
    Patents/Royalties
    Patents held by my employer in which i named as an inventor
    Grants
    • Agency: 
      AstraZeneca
      Dates: 
      2013-2020
    • Agency: 
      J&J
      Dates: 
      2017-2020
    • Agency: 
      EFPIA companies via EU-IMI
      Dates: 
      2012-2020

Liu Shi

  • Nothing to Disclose

Madhav Thambisetty

  • Nothing to Disclose

Sarah Westwood

  • Nothing to Disclose